אזילקט
teva israel ltd - rasagiline as mesylate - טבליה - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
אזילקט
teva pharmaceutical industries ltd, israel - rasagiline as mesylate - טבליה - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
אזילקט
teva pharmaceutical industries ltd, israel - rasagiline as mesylate - טבליה - rasagiline as mesylate 1 mg - rasagiline - rasagiline - azilect is indicated for the treatment of idiopathic parkinson's disease (pd) as monotherapy (without levodopa)or as adjunct therapy (with levodopa) in patients with end of dose fluctuations.
רסג'ילין סנדוז 1 מג
novartis israel ltd - rasagiline as tartrate - טבליה - rasagiline as tartrate 1 mg - rasagiline
אזילקט
teva pharmaceutical industries ltd, israel - rasagiline as mesylate - טבליה - rasagiline as mesylate 1 mg - rasagiline
רסג'ילין – תרימה
trima israel pharmaceutical products maabarot ltd - rasagiline as mesylate - טבליה - rasagiline as mesylate 1 mg - rasagiline
ראסאג'ילין אינובמד
inovamed ltd - rasagiline as hemitartrate - טבליה - rasagiline as hemitartrate 1 mg - rasagiline
רז-אג'ילין 1 מג
raz pharmaceutics ltd, israel - rasagiline as tartrate - טבליה - rasagiline as tartrate 1 mg - rasagiline
לאייף 600
bayer israel ltd - hypericum perforatum - טבליות מצופות פילם - hypericum perforatum 612 mg - symptoms of mild to moderate depression. treatment is recommended for up to 12 weeks.
זנטק סירופ
glaxo smith kline (israel) ltd - ranitidine as hydrochloride - סירופ - ranitidine as hydrochloride 150 mg / 10 ml - ranitidine - ranitidine - h2 receptor antagonist. for treatment of duodenal ulcer and benign gastric ulcer, including that associated with nsaid agents. post-operative ulcer, oesophageal reflux disease and zollinger-ellison syndrome. prophylaxis of stress ulceration in seriously ill patients. before general anaesthesia in patients considered to be of risk acid aspiration (mendelson's syndrome).